Skip to Content
Søg Menu

DESTINY-Breast11 and Neoadjuvant T-DXd: Insights from Finland

/ Maria Sundvall / Jan Andreasen
ESMO25NBCNBrystcancer

Selvskade: Når kroppen bliver katalysator for en indre tilstand

/ Lotte Rubæk / Bo Møhl / Sofie Pohl
PsykiatriPårørende

BestPractice Nordic udnævner Gitte Broholm som ny Chief Commercial Officer

/ BestPractice Nordic

Lung Cancer Insights: What’s New in the Field – January Update

/ Jan Andreasen / Amanda Feldballe Bernholm
lung cancer-highlightsLungecancer

Danish and Nordic Lung Cancer Insights – January Update

/ Jan Andreasen / Amanda Feldballe Bernholm
lung cancer-highlightsLungecancer

Behandling af ALK-positiv NSCLC med lorlatinib i 1. linje giver markante kliniske fordele 

/ Jon Alexander Lykkegaard Andersen / Jan Andreasen
NSCLCLungecancer

Osteoporose: Biosimilære lægemidler giver samfundsøkonomisk gevinst uden tab af effekt og sikkerhed

/ Peter Vestergaard / Jan Andreasen
Biosimilær behandlingOsteoporose

Emerging Treatment for High-Risk HER2-Positive Early Breast Cancer — A new therapeutic option for the primary refractory patients 

/ Jan Andreasen
ESMO25Brystcancer

Basal Cell Carcinoma Depth Variation by Anatomical Location

/ Harisankar Anantharajan / Luit Penninga / Peter Bjerring / Carsten Sauer Mikkelsen
Hudcancer

Skin of the Earth: Ochre as a Natural Photoprotectant in the Himba Tradition—The First Sunscreen in Human History?!

/ Carsten Sauer Mikkelsen / Firas Al-Niaimi / Luit Penninga / Harisankar Anantharajan / Peter Bjerring / Margareth A. Olivier / Giovanni Damiani
Back to top